<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr32-1534735418756736">
 <label>32</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Atkins</surname>
    <given-names>MB</given-names>
   </name>
   <name>
    <surname>Lotze</surname>
    <given-names>MT</given-names>
   </name>
   <name>
    <surname>Dutcher</surname>
    <given-names>JP</given-names>
   </name>
   <etal>et al</etal>
  </person-group>
  <article-title>High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993</article-title>. 
  <source>J Clin Oncol</source>. 
  <year>1999</year>;
  <volume>17</volume>:
  <fpage>2105</fpage>-
  <lpage>2116</lpage>.
  <pub-id pub-id-type="pmid">10561265</pub-id>
 </mixed-citation>
</ref>
